Harmony Biosciences
3 known investors
Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases. The company serves patients, families, and advocates in the rare disease community through novel drug development and patient-centered approaches.
BiotechHealthtechMedical Devices
Founders & leadership
JM
Jeffrey M. Dayno, M.D.President and Chief Executive Officer
Investors · 3
In the news
- H.C. Wainwright reiterates Harmony Biosciences stock rating on strong Q2 results By Investing.cominvesting.com · 2026
- Harmony Biosciences reports record Q2 revenue, CFO departure By Investing.cominvesting.com · 2026
- Harmony Biosciences Announces Preliminary Q2 Revenue, CFO Transition — Says Executive’s Departure Not Due To Any Disagreementstocktwits.com · 2026
- Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?finance.yahoo.com · 2026
- Is Harmony Biosciences Holdings (HRMY) A Bargain After Its Neuroscience Pipeline Push? - Simply Wall St Newssimplywall.st · 2026
- Harmony Biosciences - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxntracxn.com · 2021